BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38855370)

  • 21. Melatonin attenuates sepsis-induced cardiac dysfunction via a PI3K/Akt-dependent mechanism.
    An R; Zhao L; Xi C; Li H; Shen G; Liu H; Zhang S; Sun L
    Basic Res Cardiol; 2016 Jan; 111(1):8. PubMed ID: 26671026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annexin A1 Mimetic Peptide AC2-26 Inhibits Sepsis-induced Cardiomyocyte Apoptosis through LXA4/PI3K/AKT Signaling Pathway.
    Zhang L; Zheng YL; Hu RH; Zhu L; Hu CC; Cheng F; Li S; Li JG
    Curr Med Sci; 2018 Dec; 38(6):997-1004. PubMed ID: 30536061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective Effects of MicroRNA-126 on Human Cardiac Microvascular Endothelial Cells Against Hypoxia/Reoxygenation-Induced Injury and Inflammatory Response by Activating PI3K/Akt/eNOS Signaling Pathway.
    Yang HH; Chen Y; Gao CY; Cui ZT; Yao JM
    Cell Physiol Biochem; 2017; 42(2):506-518. PubMed ID: 28578351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Xuebijing Injection Ameliorates H
    Geng P; Ling BY; Zhang HL; Xiong JL; Wang Y; Yu F; Tan DY; Xu JY; Wang HH
    Chin J Integr Med; 2022 Feb; 28(2):116-123. PubMed ID: 34874518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparison of effects of Xuebijing injection and its component hydroxysafflor yellow A on coagulation and survival rates of septic rats].
    Ren C; Yao R; Wang L; Liu Q; Wu Y; Dong N; Yao Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Oct; 33(10):1198-1202. PubMed ID: 34955128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xuebijing Injection () and Resolvin D1 Synergize Regulate Leukocyte Adhesion and Improve Survival Rate in Mice with Sepsis-Induced Lung Injury.
    Zhang SK; Zhuo YZ; Li CX; Yang L; Gao HW; Wang XM
    Chin J Integr Med; 2018 Apr; 24(4):272-277. PubMed ID: 28497397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examining the effector mechanisms of Xuebijing injection on COVID-19 based on network pharmacology.
    Zheng WJ; Yan Q; Ni YS; Zhan SF; Yang LL; Zhuang HF; Liu XH; Jiang Y
    BioData Min; 2020; 13():17. PubMed ID: 33082858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Xuebijing Protects Against Septic Acute Liver Injury Based on Regulation of GSK-3β Pathway.
    Cao L; Li Z; Ren Y; Wang M; Yang Z; Zhang W; Han X; Yao M; Sun Z; Nie S
    Front Pharmacol; 2021; 12():627716. PubMed ID: 33995024
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H
    Liu J; Li J; Tian P; Guli B; Weng G; Li L; Cheng Q
    Exp Ther Med; 2019 May; 17(5):4064-4072. PubMed ID: 31007743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Role and mechanism of SIRT1 in regulating Nrf2/HO-1 signaling pathway in septic liver injury].
    Chen M; Zhang Y; Wang Y; Gulifeire T; Yu X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jun; 35(6):598-603. PubMed ID: 37366125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Xuebijing injection improve pulmonary vascular barrier function in ARDS by up-regulating claudin-5 expression through PI3K/Akt/FOXO1 signaling pathway].
    Geng P; Xiong J; Yu F; Wang H; Wang Y; Xu M; Ling B; Ma A; Zheng R
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Feb; 34(2):145-150. PubMed ID: 35387719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paeoniflorin and Hydroxysafflor Yellow A in Xuebijing Injection Attenuate Sepsis-Induced Cardiac Dysfunction and Inhibit Proinflammatory Cytokine Production.
    Wang XT; Peng Z; An YY; Shang T; Xiao G; He S; Chen X; Zhang H; Wang Y; Wang T; Zhang JH; Gao X; Zhu Y; Feng Y
    Front Pharmacol; 2020; 11():614024. PubMed ID: 33986658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant
    Li T; Qian Y; Miao Z; Zheng P; Shi T; Jiang X; Pan L; Qian F; Yang G; An H; Zheng Y
    Front Pharmacol; 2020; 11():104. PubMed ID: 32153410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xuebijing injection reduces organ injuries and improves survival by attenuating inflammatory responses and endothelial injury in heatstroke mice.
    Xu Q; Liu J; Guo X; Tang Y; Zhou G; Liu Y; Huang Q; Geng Y; Liu Z; Su L
    BMC Complement Altern Med; 2015 Feb; 15():4. PubMed ID: 25653103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Protective Effect of Mesenchymal Stem Cell Transplantation on Intestinal Injury in Septic Mice and Its Mechanism].
    Deng J; Huang SQ; Liu JT; Li W; Zeng JR; Shi HQ; Sun HY
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):565-573. PubMed ID: 37248585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.
    Liu MW; Liu R; Wu HY; Zhang W; Xia J; Dong MN; Yu W; Wang Q; Xie FM; Wang R; Huang YQ; Qian CY
    Int J Mol Med; 2016 Nov; 38(5):1419-1432. PubMed ID: 27666960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tong‑fu‑li‑fei decoction attenuates immunosuppression to protect the intestinal‑mucosal barrier in sepsis by inhibiting the PD‑1/PD‑L1 signaling pathway.
    Chen L; Li L; Zou S; Liao Q; Lv B
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34633052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GC/MS-based metabonomics approach reveals effects of Xuebijing injection in CLP induced septic rats.
    Jiang Y; Zou L; Liu S; Liu X; Chen F; Liu X; Zhu Y
    Biomed Pharmacother; 2019 Sep; 117():109163. PubMed ID: 31238257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xuebijing Administration Alleviates Pulmonary Endothelial Inflammation and Coagulation Dysregulation in the Early Phase of Sepsis in Rats.
    Lv J; Guo X; Zhao H; Zhou G; An Y
    J Clin Med; 2022 Nov; 11(22):. PubMed ID: 36431172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Preliminary study on the efficacy of ultrasound therapy in the rat model of sepsis].
    Huang H; Cai Y; Liang L; Shao W; Xu S; Zhou Y; Sun P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Sep; 33(9):1110-1115. PubMed ID: 34839871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.